CRISPR Therapeutics AG - CRSP

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$4.349B

QoQ value delta ($000)

+$448.3M (+11.49%)

Implied price effect (QoQ)

+14.8%

Total shares

79,688,360

QoQ shares delta

-2,362,569 (-2.88%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 530 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
ARK Investment Management LLC	515,999	9,460,939	3.35%
BlackRock, Inc.	455,353	8,348,977	0.01%
Orbis Allan Gray Ltd	297,197	5,449,161	1.02%
Capital World Investors	259,039	4,749,525	0.03%
STATE STREET CORP	235,703	4,321,666	0.01%
GSK plc	175,652	3,220,627	29.17%
GEODE CAPITAL MANAGEMENT, LLC	136,919	2,509,915	0.01%
T. Rowe Price Investment Management, Inc.	111,972	2,053,017	0.07%
SR ONE CAPITAL MANAGEMENT, LP	111,194	2,038,763	10.7%
TWO SIGMA INVESTMENTS, LP	108,459	1,988,621	0.08%
FMR LLC	104,089	1,908,503	0.0%
Sumitomo Mitsui Trust Group, Inc.	93,848	1,720,734	0.05%
Amova Asset Management Americas, Inc.	93,762	1,720,097	1.21%
EcoR1 Capital, LLC	75,771	1,389,276	3.68%
UBS Group AG	71,992	1,319,999	0.01%
Capital International Investors	69,178	1,268,407	0.01%
VANGUARD CAPITAL MANAGEMENT LLC	64,457	1,181,847	0.0%
BANK OF AMERICA CORP /DE/	62,999	1,155,105	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	59,518	1,091,278	0.0%
NEA Management Company, LLC	57,734	1,058,570	3.64%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	57,694	1,057,837	0.01%
CITADEL ADVISORS LLC	55,199	1,012,096	0.01%
D. E. Shaw & Co., Inc.	54,982	1,008,112	0.03%
MORGAN STANLEY	47,992	879,949	0.0%
NORTHERN TRUST CORP	47,072	863,091	0.01%